Geftilon 250mg Tablet is prescribed for cancer treatment as it targets the epidermal growth factor receptor EGFR present in both normal and cancer cells disrupting signals necessary for cancer cell growth Gefitinib a cancer medication inhibits cancer cell growth by targeting the EGFR found in both healthy and cancerous cells By inhibiting specific proteins associated with this receptor Gefitinib interrupts the communication pathways crucial for cancer cell growth and survival Follow the prescribed dose and duration as directed by your doctor taking the medicine with or without food Common side effects include diarrhea dry skin loss of appetite nausea rash stomatitis vomiting weakness and weight loss It is associated with an increased risk of interstitial lung disease so patients should be monitored for symptoms such as cough difficulty breathing and fever Prompt medical attention is necessary if these symptoms occur If a dose is missed take it when remembered but avoid doubling doses Consult your doctor for guidance on managing missed doses effectively
